Clinical Trial Update: Efficacy of Invitro Expanded Bone Marrow Derived Allogeneic Mesenchymal Stem Cell Transplantation Via Portal Vein or Hepatic Artery or Peripheral Vein in Patients With Wilson Cirrhosis [NA]

View source ↗

Summary

A completed clinical trial evaluating the efficacy of Invitro-expanded allogeneic bone marrow-derived mesenchymal stem cell transplantation delivered via portal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Wilson Disease

Drugs mentioned

• Invitro Expanded Bone Marrow Derived Allogeneic Mesenchymal Stem Cells (bone marrow-derived mesenchymal stem cells)

Snippet

Sponsor: Murat Kantarcioglu | Conditions: Wilson's Disease | NA | Status: COMPLETED